Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 9,274 |
|
|||||
| News | - | ||||||
| Day High | 3.2197 | Low High |
|||||
| Day Low | 2.91 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SAB Biotherapeutics Inc | SABS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.1036 | 3.65% | 2.9436 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.91 | 2.91 | 3.2197 | 2.9436 | 2.84 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 108 | 9,274 | $ 3.01 | $ 27,944 | - | 2.36 - 10.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 11 | $ 2.98 | USD |
SAB Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 27.12M | 9.23M | - | 2.24M | -42.19M | -4.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SAB Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SABS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.63 | 3.2197 | 2.4701 | 2.79 | 17,793 | 0.3136 | 11.92% |
| 1 Month | 3.85 | 4.23 | 2.36 | 2.97 | 35,103 | -0.9064 | -23.54% |
| 3 Months | 6.05 | 6.30 | 2.36 | 3.55 | 17,134 | -3.11 | -51.35% |
| 6 Months | 8.80 | 9.00 | 2.36 | 5.69 | 26,054 | -5.86 | -66.55% |
| 1 Year | 9.50 | 10.50 | 2.36 | 7.47 | 42,526 | -6.56 | -69.01% |
| 3 Years | 78.00 | 120.90 | 2.36 | 25.72 | 225,936 | -75.06 | -96.23% |
| 5 Years | 78.00 | 120.90 | 2.36 | 25.72 | 225,936 | -75.06 | -96.23% |
SAB Biotherapeutics Description
| SAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing fully human, multi-targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma, to treat and prevent immune and autoimmune disorders. The company's lead asset, SAB-142, targets Type-1 diabetes (T1D) with a disease-modifying therapeutic approach that aims at changing the treatment paradigm by delaying onset and potentially preventing disease progression. |
